Our main priority is to ensure the availability of life-saving drugs for the citizens of Kazakhstan and Central Asia. SANTO plant has advanced technologies, high-tech equipment and qualified specialists producing drugs in accordance with international quality standards. This is our contribution to the care of public health and national security.Adam Aleksiejuk
SANTO CEO
1
billion
tablets
255
million
capsules
7,5
million
sachets
135
tons
of tablet mass by wet granulation
46.7
million
vials with cephalosporin antibiotics
15.5
million
vials with penem/mycin antibiotics
8.4
tons
of million vials with non-sterile liquid dosage forms.
250
million
injection ampoules
![](/wp-content/themes/santo/static/img/content/History-1.jpg)
1882
Plant establishment
The SANTO plant is one of the oldest pharmaceutical
enterprises in Kazakhstan. It was founded in 1882 by
merchants Ivanov and Savenkov as a plant for the production
of the Santonin drug - an anthelmintic agent based on
wormwood (Artemisia cina). Today, a sprig of wormwood adorns
the coat of arms of Shymkent, for which the opening of a
pharmaceutical enterprise was a powerful impetus for
development.
![](/wp-content/themes/santo/static/img/content/History-2.jpg)
1917-1991
Working in the USSR period
During the Soviet period, the plant was the largest producer
of pharmaceutical substances from raw plant materials and a
manufacturer of narcotic agents.
![](/wp-content/themes/santo/static/img/content/History-3.jpg)
1993
Reorganization into Chimpharm JSC
Commencement of the pharmaceutical production large-scale
modernization in accordance with the international GMP
quality standard within the framework of the implementation
of an investment project worth about 108 million US dollars.
![](/wp-content/themes/santo/static/img/content/History-4.jpg)
2011
Merger into Polpharma Group
Commencement of the pharmaceutical production large-scale
modernization in accordance with the international GMP
quality standard within the framework of the implementation
of an investment project worth about 108 million US dollars.
![](/wp-content/themes/santo/static/img/content/History-5.jpg)
2014
Launching production of medicines in ampoules and
infusions
A new production workshop was opened within the framework of
the FIID State Program. At the moment, parenteral solutions
of large and small dosages are produced in this workshop.
![](/wp-content/themes/santo/static/img/content/History-6.jpg)
2016
Launching production of antibiotic powders (GMP)
A new workshop for the production of antibiotic powders
(cephalosporins and penems/mycins) complies with the
international GMP standard. The production is arranged on
two separate lines.
![](/wp-content/themes/santo/static/img/content/History-7.jpg)
2017
Launching production of oral solid dosage forms (GMP)
A new workshop for the production of oral solid dosage forms
by dry granulation method was launched as part of the
plant’s 135th anniversary celebration.
![](/wp-content/themes/santo/static/img/content/History-8.jpg)
2018
Commencement of production of oral liquid dosage forms
(GMP) as well as modernization of the warehouse (GDP)
As part of the product range expansion, a new manufacturing
field was introduced - the production of oral liquid dosage
forms. GMP recertification was successfully passed, and a
GDP compliance certificate was obtained for the modernized
pharmacy warehouse of the plant.
![](/wp-content/themes/santo/static/img/content/History-11.jpg)
2019
Commencement of production of oral solid dosage forms by wet
granulation method (GMP); the opening of the Digital
Engineering and Education Center as well as a sculpture
named “Looking into the Future” at the SANTO plant.
![](/wp-content/themes/santo/static/img/content/awwar2020.png)
2020
Winning in the BEST RX CORPORATION OF KAZAKHSTAN 2020
nomination
For the first time, SANTO became a winner of IQVIA RX &
CONSUMER HEALTH AWARDS 2020 in the pharmaceutical market of
Kazakhstan in the BEST RX CORPORATION KAZAKHSTAN 2020
nomination.
![](/wp-content/themes/santo/static/img/content/pariz2021.jpg)
2021
Winning the PARYZ Republican Contest
For the first time, SANTO became a winner of the Paryz-2021
Republican Contest on Social Responsibility in the
nomination “The Best Socially Responsible Enterprise”.
![](/wp-content/themes/santo/static/img/content/aww2021.jpg)
2021
Winning the EURASIAN PHARMA AWARD Contest
For the first time, SANTO became the winner of the Eurasian
Pharma Award-2021 Contest in the nomination “Local Company
of the Year”.
![](/wp-content/uploads/2024/05/viortis-2.jpg)
2022
Market leader
SANTO became the market leader according to the results of a study by the independent consulting company Vi ortis
![](/wp-content/uploads/2024/05/IMG_20240522_135441-min.jpg)
2023
Launch of new sites in the workshop of CTPLS No. 3
Opening of a solid medicine production site using compaction technology (dry granulation) and a new tablet coating site in the PPSM plant No. 3
![](https://santo.kz/wp-content/uploads/2024/05/КОМПАНИЯ_SANTO_ПОЛУЧИЛА_НАГРАДЫ_EURASIAN_PHARMA_AWARDS.jpg)
2023
Victory at the Eurasian Pharma Awards
The winner in the Eurasian Pharma Awards in the nominations "Local Company of the Year" and "Exporter of the Year"
![](/wp-content/uploads/2024/05/eu_gmp_logo_approved.jpg)
2023
Request to the EU in order to obtain a GMP certificate
SANTO sent a request to the European Union to inspect the plant in Kazakhstan in order to obtain a GMP certificate of the European standard